FDA rejects anticipated hypercholesterolemia drug
   
 
Home | Support
 
Headline News:
FDA
Fake Drugs
Drug Testing
 
 
FDA rejects anticipated hypercholesterolemia drug
7 May 08, 20:11
A new drug application submitted by Merck & Company Inc. for the treatment of primary hypercholesterolemia and mixed dyslipidemia was rejected last week by ...
more

 

 
© 2007 nafdacnigeria.org